$PLUS

Earnings call transcript: ePlus tops Q1 2026 estimates as AI demand lifts shares

ePlus (PLUS) reported Q1 fiscal 2027 adjusted EPS of $1.28 versus $1.19 expected, on revenue of $649.1 million versus $631.35 million. The company cited strong AI infrastructure and security demand, with managed services surpassing $50 million. Gross margin fell to 23.3% from 23.9%. Shares rose 3.62% to $97.05, and 2.01% after-hours to $99.

Original reporting
Published Aug 5, 2026, 3:57 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 6:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$PLUS
Bullish
high confidence
Mentioned
$PLUS
Relevance
8/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$PLUSBullishMed
01

Why it matters

Traders can reassess near-term expectations around order conversion into revenue and whether AI/security strength offsets gross margin and EBITDA declines, with capital return via a new buyback authorization.

02

Market read

A concrete earnings beat with intact guidance and a new repurchase authorization, offset by profitability deterioration and conversion timing risk.

03

What to watch

Open orders are large but not fully ratable, so revenue timing may shift into later quarters, and professional services delays plus memory shortages could keep profitability under pressure.

Relevance 8/10Novelty 7/10Timing: after-hours reaction following Q1 fiscal 2027 earnings release

Background

ePlus reported Q1 fiscal 2027 results, emphasizing AI infrastructure and security demand, while acknowledging margin pressure and project timing issues.

Company-level read

Ticker impact

$PLUSBullishHigh confidence
Context

ePlus beat Q1 fiscal 2027 estimates with adjusted EPS of $1.28 vs $1.19 and revenue of $649.1M vs $631.35M, lifting shares after-hours.

Expected impact

Likely continued post-earnings momentum near term, with volatility driven by investors focusing on gross margin pressure and order-to-revenue conversion timing.

Evidence & confidence

The article provides both the beat (EPS and revenue) and the offsetting profitability deterioration (gross margin down to 23.3% and adjusted EBITDA down), plus a specific capital return action (repurchase authorization) and unchanged guidance.

Market effects

Reinforces demand read-through for IT security and AI infrastructure/networking integrators, while highlighting margin pressure risk in the group.

No specific regional market impact beyond US-listed small-cap IT services sentiment.

Memory shortages and geopolitical uncertainty cited as headwinds are broadly relevant to global IT hardware and services supply chains.

Counterpoint

The beat may be less durable because gross margin and adjusted EBITDA both declined, implying earnings quality could weaken as order conversion lags.

Key entities

  • ePlus Inc

    Reported Q1 fiscal 2027 adjusted EPS and revenue beat, discussed AI/security demand, margin pressure, and maintained fiscal 2027 guidance.

  • Mark Marron

    CEO commentary on healthy demand and an agentic AI platform with Cisco and Nvidia.

  • Elaine Marion

    CFO commentary on product and managed services growth offsetting professional services decline.

Related articles

$PLUSMedAI 8/10

Why ePlus (PLUS) Shares Are Plunging Today

ePlus (NASDAQ: PLUS) shares fell about 5% after the company reported Q2 2026 results. Revenue rose 1.9% year over year to $649.1 million and adjusted EPS was $1.28, both above Wall Street estimates. Despite the beat, investors focused on declining adjusted operating and free cash flow margins and a forecast of about 2% full-year EPS growth. Shares later traded near $92.31.

$PLUSMed

ePlus (NASDAQ:PLUS) Surprises With Q2 CY2026 Sales

ePlus (NASDAQ:PLUS) reported Q2 CY2026 revenue of $649.1 million, up 1.9% year on year, exceeding market expectations. Non-GAAP profit was $1.28 per share, 11.8% above analysts’ consensus. The company cited extended lead times and shipment delays tied to an ongoing memory chip shortage.

$PLUSMed

EPLUS INC (PLUS): Results of Operations and Financial Condition

EPLUS INC (PLUS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 5 ef20079242_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 ePlus Reports First Quarter Fiscal Year 2027 Financial Results Managed Services Delivers Strong Performance and Increases Recurring Revenue ~ Reiterates Fiscal 2027 Guidance ~ First Quarter of Fiscal Year 2027 ● Net sales

$PLUSMed

ePlus Reports First Quarter Fiscal Year 2027 Financial Results

ePlus (NASDAQ: PLUS) reported Q1 FY2027 results for the three months ended June 30, 2026. Net sales rose 1.0% to $649.1 million and services revenue rose 2.6% to $119.4 million, while gross profit fell 1.5% to $151.3 million. Net earnings from continuing ops declined 5.4% to $30.3 million and adjusted EBITDA fell 9.2% to $47.8 million. The company reiterated FY2027 mid-single-digit growth guidance and declared a $0.27 quarterly dividend.

$PLUSMed

PageGroup & Oxford Nanopore: Markets live

PageGroup shares rose over 11% after it reported Q2 gross profit of £198m, down 0.2% year on year but ahead of analyst expectations, and said it sees signs of market normalisation. ME Group International gained about 11% after interim results showed flat £154m sales. Plus500 shares fell on weaker cash margin, and Oxford Nanopore dropped 12% after H1 sales missed expectations at £116.5m.

$PLUSMedAI 8/10

ePlus (NASDAQ:PLUS) Issues Earnings Results

ePlus (NASDAQ:PLUS) reported quarterly EPS of $1.00, slightly above analysts’ $0.98 consensus, and revenue of $576.17 million versus $569.25 million expected, according to FiscalAI. The stock fell $0.54 to $88.65 on Thursday. Institutional investors hold 93.8%.